Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease

Mov Disord. 2018 Sep;33(9):1488-1492. doi: 10.1002/mds.27365. Epub 2018 May 14.

Abstract

Background Nigral degeneration patterns differ between PSP and PD. However, the relationship between nigral degeneration and midbrain atrophy in PSP remains unclear. Objective We analyzed differences and relationships between nigral degeneration and midbrain atrophy in PSP and PD. Methods Neuromelanin-sensitive MRI and midbrain volumetry were performed in 11 PSP patients, 24 PD patients, and 10 controls to measure the neuromelanin-sensitive SNpc area and midbrain volume. Results The neuromelanin-sensitive SNpc area and midbrain volume were significantly smaller in PSP patients compared with PD patients and controls. Motor deficits were inversely correlated with neuromelanin-sensitive SNpc area in PD, but not PSP patients. There was no significant correlation between neuromelanin-sensitive SNpc area and midbrain volume in either disease group. Midbrain volumetry discriminated PSP from PD. Diagnostic accuracy was improved when neuromelanin-sensitive MRI analysis was added. Conclusions Neuromelanin-sensitive MRI and midbrain volumetry may reflect the clinical and pathological characteristics of PSP and PD. Combining neuromelanin-sensitive MRI and midbrain volumetry may be useful for differentiating PSP from PD. © 2018 International Parkinson and Movement Disorder Society.

Keywords: Parkinson's disease; midbrain; neuromelanin; progressive supranuclear palsy; volumetry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Melanins / metabolism*
  • Mesencephalon / diagnostic imaging*
  • Mesencephalon / metabolism*
  • Parkinson Disease / diagnostic imaging*
  • Prospective Studies
  • ROC Curve
  • Severity of Illness Index
  • Substantia Nigra / diagnostic imaging
  • Substantia Nigra / metabolism
  • Supranuclear Palsy, Progressive / diagnostic imaging*

Substances

  • Melanins
  • neuromelanin